Update

Telehealth rules, which were created during the pandemic, allowed for the prescribing of controlled substances without an in-person visit, will stay in place until November 11.

The law, which took effect June 27, requires employers to provide "reasonable accommodations" to pregnant workers, but public health experts say not nearly enough is known about which work circumstances are dangerous.

Hospitals, insurers like Aetna-CVS Health and corporate giants like Amazon are on a buying spree, snapping up primary care practices, furthering a move away from the neighborhood doctor.

Drugmakers have been rushing to develop obesity pills (to rival obesity shots like Wegovy), angling for a piece of a market that some estimate will one day be worth as much as $100 billion.

The main cause, experts agree, is the underlying weakness of the generic drug industry, which are made mostly overseas because U.S. manufacturers are setting their sights instead on high-priced drugs with plump profit margins.

With bipartisan consensus in Congress that Americans need help on health care costs, it's likely bills will be introduced to expand the opportunity for individuals to contribute to a health savings account, says the ECFC.

The Telehealth Benefit Expansion for Workers Act would allow employers to offer workers standalone telehealth benefits, however, some detractors say it leaves employees unprotected from deceptive marketing practices.

The ERISA Industry Committee, an employer advocacy group, implored the IRS in a letter to clarify how sponsors can implement new SECURE 2.0 features - and also offered recommendations for improving health care benefits.